Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

417 trials

NCT07516366
Recruiting
Testing the Safety and Feasibility of Immunotherapy Drugs, Botensilimab and Balstilimab, Before Surgery for Clear Cell Renal Cell Carcinoma, NEO RoBOT Trial
Phase 2 · United States · 5 sites
Registry update: 21 Oct 2026
NCT06960798
Recruiting
Characterizing the Genomic Landscape of Cancer in Native American Populations (NAT-Geno)
Not applicable · United States · 1 site
Registry update: 13 Oct 2026
NCT07714018
Recruiting
Comparing Two Weight Loss Programs for the Prevention of Kidney Cancer Progression Among Patients With Small Renal Masses on Active Surveillance
Not applicable · United States · 1 site
Registry update: 16 Oct 2026
NCT07888608
Recruiting
Effect of Non-Clamping and Sutureless Technique on Postoperative Renal Function in Robot-Assisted Partial Nephrectomy
Not applicable · China · 1 site
Registry update: 22 Oct 2026
NCT07872553
Recruiting
A Study of Treatment Delivery Preference In People With Kidney Cancer
Phase 4 · United States · 7 sites
Registry update: 16 Oct 2026
NCT07704970
Recruiting
QLESP Block for Pain Control in Robotic Partial Nephrectomy
Not applicable · China · 1 site
Registry update: 25 Sept 2026
NCT07833085
Recruiting
CAIX-targeted PET/CT in Solid Tumors
Not applicable · China · 1 site
Registry update: 13 Oct 2026
NCT07748988
Recruiting
Casdatifan for the Treatment of Refractory Metastatic Clear Cell Renal Cell Carcinoma
Phase 1 · United States · 1 site
Registry update: 25 Sept 2026
NCT07828704
Recruiting
Photodynamic Diagnosis of Kidney Cancer Using Fluorescence Endoscopy and Oral 5-ALA
Phase 2 · United States · 1 site
Registry update: 18 Sept 2026
NCT06948552
Recruiting
Photodynamic Diagnosis of Upper Tract Urothelial Carcinoma Using Fluorescence Endoscopy and Oral 5-ALA
Phase 2 · United States · 1 site
Registry update: 18 Sept 2026
NCT07285538
Recruiting
Stereotactic Body RadioTherapy With Continuous Tracking for Primary and Secondary Renal Cancer
Not applicable · Italy · 1 site
Registry update: 27 Oct 2026
NCT07039474
Recruiting
The Application of 18F-G1 PET/CT Targeting Granzyme B in the Pan-cancer Immunotherapy
Not applicable · China · 1 site
Registry update: 28 Sept 2026
NCT07803315
Recruiting
Hyperspectral Imaging in Robot-Assisted Partial Nephrectomy
Not applicable · Germany · 1 site
Registry update: 3 Sept 2026
NCT07874542
Recruiting
Plasma DNA Methylation for Preoperative Classification of Renal Masses
Not applicable · China · 1 site
Registry update: 15 Oct 2026
NCT07297667
Recruiting
GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours
Phase 1 · Canada · 4 sites
Registry update: 16 Oct 2026
NCT07226544
Recruiting
Ivonescimab Prior to Surgery for the Treatment of High-Risk Localized Clear Cell Renal Cell Cancer
Phase 2 · United States · 1 site
Registry update: 23 Oct 2026
NCT07770802
Recruiting
Clinical Study of HS-IT101 Injection in the Treatment of Advanced Renal Cancer(FASTIL-Renal01)
Phase 1 · China · 2 sites
Registry update: 14 Oct 2026
NCT07767500
Recruiting
Stereotactic MR-Adaptive Radiation Therapy for Early-stage Renal Cancer
Not applicable · United States · 1 site
Registry update: 21 Aug 2026
NCT07744932
Recruiting
SABR Combined With Axitinib and Toripalimab for Oligometastatic Renal Cell Carcinoma
Phase 2 · China · 1 site
Registry update: 4 Aug 2026
NCT07341737
Recruiting
SL-28 for Advanced Solid Tumours
Phase 1/2 · Australia · 3 sites
Registry update: 15 Sept 2026

Ordered by registry start date. Freshness and sponsorship never change the order.